James Reuben
James Reuben
Professor, University of Texas MD Anderson Cancer Center
Verified email at mdanderson.org
Cited by
Cited by
The genetics of Caenorhabditis elegans
S Brenner
Genetics 77 (1), 71-94, 1974
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli, GT Budd, MJ Ellis, A Stopeck, J Matera, MC Miller, ...
New England Journal of Medicine 351 (8), 781-791, 2004
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli, DF Hayes, GT Budd, MJ Ellis, A Stopeck, JM Reuben, ...
Journal of clinical oncology 23 (7), 1420-1430, 2005
Alpha interferon for induction of remission in hairy-cell leukemia
JR Quesada, J Reuben, JT Manning, EM Hersh, JU Gutterman
New England Journal of Medicine 310 (1), 15-18, 1984
Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma
E Olsen, M Duvic, A Frankel, Y Kim, A Martin, E Vonderheid, B Jegasothy, ...
Journal of Clinical Oncology 19 (2), 376-388, 2001
Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206
A Ribas, LH Camacho, G Lopez-Berestein, D Pavlov, CA Bulanhagui, ...
J Clin Oncol 23 (896877.25), 2005
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine‐immunologic model of cancer symptoms
CS Cleeland, GJ Bennett, R Dantzer, PM Dougherty, AJ Dunn, CA Meyers, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2003
Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study
G Lopez-Berestein, V Fainstein, R Hopfer, K Mehta, MP Sullivan, ...
Journal of Infectious Diseases 151 (4), 704-710, 1985
Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia
A Ferrajoli, BN Lee, EJ Schlette, SM O'Brien, H Gao, S Wen, WG Wierda, ...
Blood, The Journal of the American Society of Hematology 111 (11), 5291-5297, 2008
Soluble TNF-α receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight
WT Shearer, JM Reuben, JM Mullington, NJ Price, BN Lee, EOB Smith, ...
Journal of allergy and clinical immunology 107 (1), 165-170, 2001
Nuclear factor–κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis
AC Bharti, S Shishodia, JM Reuben, D Weber, R Alexanian, ...
Blood 103 (8), 3175-3184, 2004
Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions
JP Cata, H Wang, V Gottumukkala, J Reuben, DI Sessler
British journal of anaesthesia 110 (5), 690-701, 2013
Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome
L Fayad, MJ Keating, JM Reuben, S O'Brien, BN Lee, S Lerner, ...
Blood, The Journal of the American Society of Hematology 97 (1), 256-263, 2001
A cytokine-based neuroimmunologic mechanism of cancer-related symptoms
BN Lee, R Dantzer, KE Langley, GJ Bennett, PM Dougherty, AJ Dunn, ...
Neuroimmunomodulation 11 (5), 279-292, 2004
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy
L Pusztai, TR Mendoza, JM Reuben, MM Martinez, JS Willey, J Lara, ...
Cytokine 25 (3), 94-102, 2004
Treatment of hairy cell leukemia with recombinant alpha-interferon
JR Quesada, EM Hersh, J Manning, J Reuben, M Keating, E Schnipper, ...
Phase I Trial of a Ligand Fusion-Protein (DAB389IL-2) in Lymphomas Expressing the Receptor for Interkeukin-2
CF LeMaistre, MN Saleh, TM Kuzel, F Foss, LC Platanias, G Schwartz, ...
Blood, The Journal of the American Society of Hematology 91 (2), 399-405, 1998
Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system
E Andreopoulou, LY Yang, KM Rangel, JM Reuben, L Hsu, ...
International journal of cancer 130 (7), 1590-1597, 2012
Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor
CF LeMaistre, C Meneghetti, M Rosenblum, J Reuben, K Parker, J Shaw, ...
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
M Giuliano, A Giordano, S Jackson, KR Hess, U De Giorgi, M Mego, ...
Breast Cancer Research 13 (3), 1-9, 2011
The system can't perform the operation now. Try again later.
Articles 1–20